My ePortfolio Register   

Transforming patient care through translational research

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.05.17
Views: 708

Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain

Prof Prat speaks with ecancer at IMPAKT 2017 about establishing biomarkers for breast cancer.

He highlights differing breast cancer subtypes which have established sensitivities to endocrine or cell therapy, and looks beyond chemotherapy to combination and targeted therapies.

Prof Prat compares translational successes with lung cancer as a guide for further trials of breast cancer treatments, and considers the importance of world-wide collaboration.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence